Difference between revisions of "Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) (Q10740)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Has Sectioning (P146): Section 2: Biology of SARS-CoV-2 (from DOI: 10.1007/s11886-020-01292-3) (Q10735), #quickstatements; #temporary_batch_1592944510830)
 
(41 intermediate revisions by the same user not shown)
Property / occurs inProperty / occurs in
-
Q10356 (Deleted Item)
+
Property / part ofProperty / part of
-
Q10356 (Deleted Item)
+
Property / Has Sectioning
 +
Property / Has Sectioning: Section 3: The Role of Host Immune Response (from DOI: 10.1007/s11886-020-01292-3) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 4: Viral Toxicity and Myocardial Injury in COVID-2 (from DOI: 10.1007/s11886-020-01292-3) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 5: Immune Responses to SARS-CoV-2 Infection and the Heart (from DOI: 10.1007/s11886-020-01292-3) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 6: Host-Specific Variations in COVID-19 Immune Response (from DOI: 10.1007/s11886-020-01292-3) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Section 8: Conclusion (from DOI: 10.1007/s11886-020-01292-3) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: Conflict of Interest (from DOI: 10.1007/s11886-020-01292-3) / rank
 +
Normal rank
Property / Has Sectioning
 +
Property / Has Sectioning: References (from DOI: 10.1007/s11886-020-01292-3) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: COVID-19 (disease - MeSH supplementary concept) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: surface glycoprotein (gene) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: seryl-tRNA synthetase 2, mitochondrial (gene) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: transmembrane serine protease 2 (gene) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: angiotensin I converting enzyme 2 (gene) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: 2019 novel coronavirus (species) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Serine (chemical - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Cardiovascular Diseases (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Infections (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Human (species) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: remdesivir (chemical - MeSH supplementary concept) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Hydroxychloroquine (chemical - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Hyperkinesis (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Sepsis (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Drug-Related Side Effects and Adverse Reactions (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Zika virus (species) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Azithromycin (chemical - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: lopinavir-ritonavir drug combination (chemical - MeSH supplementary concept) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Chloroquine (chemical - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Malaria (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Cardiac Death (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Cardiotoxicity (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: interleukin 6 (gene) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: basigin (Ok blood group) (gene) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: programmed cell death 1 (gene) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: tumor necrosis factor (gene) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: tocilizumab (chemical - MeSH supplementary concept) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: sarilumab (chemical - MeSH supplementary concept) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: eculizumab (chemical - MeSH supplementary concept) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Adalimumab (chemical - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Acute Respiratory Distress Syndrome (disease - MeSH descriptor) / rank
 +
Normal rank
Property / named entity
 +
Property / named entity: Myocarditis (disease - MeSH descriptor) / rank
 +
Normal rank
Property / Collection or Dataset of Origin
 +
Property / Collection or Dataset of Origin: Pubtator Central BioC-JSON formatted article files / rank
 +
Normal rank

Latest revision as of 19:25, 24 June 2020

Publication: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response"published as Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32; DOI: 10.1007/s11886-020-01292-3
Language Label Description Also known as
English
Section 7: Treatments for SARS-CoV-2 Infection (from DOI: 10.1007/s11886-020-01292-3)
Publication: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response"published as Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32; DOI: 10.1007/s11886-020-01292-3

    Statements

    instance of
    Segment
    0 references
    IMRaD(C) Section
    Methods
    0 references
    named entity
    Human (species)
    0 references
    Zika virus (species)
    0 references
    interleukin 6 (gene)
    0 references
     

    Sitelinks

    Retrieved from "http://wikibase.slis.ua.edu/w/index.php?title=Item:Q10740&oldid=226259"